May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
A combined approach for reconstruction of severe contraction of the conjunctival fornix using amniotic membrane transplantation and adjunctive Mitomicin C.
A. Nava–Castaneda; J.–L. Tovilla–Canales; J.–L. Tovilla–y–Pomar; M.–H. Monroy–Serrano; V. Tapia–Guerra; L. Garnica
Author Affiliations & Notes
  • A. Nava–Castaneda
    Oculoplastics, Conde de Valenciana, Mexico City, Mexico
    Oculoplastics, Instituto de Oftalmologia Fundacion Conde de Valenciana, Mexico City, Mexico
  • J.–L. Tovilla–Canales
    Oculoplastics, Conde de Valenciana, Mexico City, Mexico
  • J.–L. Tovilla–y–Pomar
    Oculoplastics, Conde de Valenciana, Mexico City, Mexico
  • M.–H. Monroy–Serrano
    Oculoplastics, Conde de Valenciana, Mexico City, Mexico
  • V. Tapia–Guerra
    Oculoplastics, Conde de Valenciana, Mexico City, Mexico
  • L. Garnica
    Oculoplastics, Conde de Valenciana, Mexico City, Mexico
  • Footnotes
    Commercial Relationships  A. Nava–Castaneda, None; J. Tovilla–Canales, None; J. Tovilla–y–Pomar, None; M. Monroy–Serrano, None; V. Tapia–Guerra, None; L. Garnica, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1482. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      A combined approach for reconstruction of severe contraction of the conjunctival fornix using amniotic membrane transplantation and adjunctive Mitomicin C.
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      A. Nava–Castaneda, J.–L. Tovilla–Canales, J.–L. Tovilla–y–Pomar, M.–H. Monroy–Serrano, V. Tapia–Guerra, L. Garnica; A combined approach for reconstruction of severe contraction of the conjunctival fornix using amniotic membrane transplantation and adjunctive Mitomicin C. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1482.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the clinical outcome of patients with severe contraction of the conjunctival fornix secondary to different ocular surface diseases, who were treated with amniotic membrane transplantation and adjunctive application of Mitomicyn C (MMC) at 0.02% . Methods: After a complete ophthalmological evaluation, patients with symblepharon who accepted the treatment and had a signed consent were included. Evaluated parameters were depth of fornix formation, ocular motility and the final integrity of the amniotic membrane graft. Technique: Once the scarred tissue is removed from the affected conjunctiva, MMC–0.02% is applied over the surgical bed using a soaked microsponge for 60 seconds. Intensive irrigation with balanced salt solution is performed to wash out the MMC. The amniotic membrane graft is then sutured with 8–0 Vicryl suture to cover the conjunctival defect, and anchored to episclera as deep as possible in the fornix. Results: Twelve eyes were treated using this technique with a mean follow–up of 8.5 months. In 9 eyes a complete resolution of the symblepharon was obtained, achieving a deep fornix formation and full globe motility. Three patients with Stevens–Johnson syndrome had recurrence of symblepharon and recquired additional procedures. No graft necrosis or scleral melting were reported. Conclusions: In this study we demonstrated that rapid epithelization due to amniotic membrane transplantation associated with the antimetabolite properties of the topical application of MMC–0.02% increases the success rate in the management of severe symblepharon. Worst results were seen in patients with autoimmune disorders. We believe our results should encourage others to use the combined technique in the reconstruction of scarred fornices. Possible secondary effects associated to MMC should also be monitored with a longer follow–up.

Keywords: conjunctiva • cornea: basic science • transplantation 
© 2004, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept